The report offers detailed coverage of Continuous Glucose Monitoring Systems industry and main market trends.
Continuous glucose monitoring systems helps to manage diabetes by providing real time values of the glucose levels and alerts to the patient in the event of hypo or hyperglycemia. This helps reduce the probability of any complications related to diabetes. In addition, CGMS offers varied benefits over other glucose monitors in monitoring the blood glucose levels of ICU patients. The major factors that drive the growth include surge in geriatric population and high prevalence of population suffering from diabetes. However, lack of adequate reimbursement for devices is the key barrier to the adoption of the devices.
The market is categorized based on component, end user, and region. The CGMS components market includes durable components such as transmitters & receivers and integrated insulin pumps; and disposable components such as sensors. The segment for sensors occupies a dominant share in the CGMS market due to recurring sales of CGMS, short scrap life, and bulk purchases. Therefore, it is deployed in diagnostic centers/clinics. Moreover, the adoption of CGMS in hospital ICUs and in-home healthcare settings has increased in the recent years.
The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Continuous Glucose Monitoring Systems by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
The report forecast global Continuous Glucose Monitoring Systems market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2026.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
First, this report covers the present status and the future prospects of the global Continuous Glucose Monitoring Systems market for 2015-2026.
In this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Abbott Laboratories
Dexcom
A. Menarini Diagnostics
Echo Therapeutics
Insulet Corporation
GlySens Incorporated
Johnson & Johnson
Medtronic
Senseonics Holdings
F. Hoffmann-La Roche
At the same time, we classify Continuous Glucose Monitoring Systems according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market by Order Type
Sensors
Transmitters & Receivers
Integrated Insulin Pumps
Market by Application
Diagnostics/Clinics
ICUs
Home Healthcare
Market Segment as follows:
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Continuous Glucose Monitoring Systems market for the forecast period 2021 - 2026?
• What are the driving forces in the Continuous Glucose Monitoring Systems market for the forecast period 2021 - 2026?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Continuous Glucose Monitoring Systems industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?
For any other requirements, please feel free to contact us and we will provide you customized report.